The Prostate Cancer Grade Assessment (PANDA) Challenge, a global artificial intelligence competition, recently published findings of their "blueprint for evaluating AI [artificial intelligence] algorithms in digital pathology" for prostate cancer patients. In the PANDA report, prostate tumours were categorized into 5 grade groups, based on the Gleason growth patterns of tumour tissue. Following the application of AI to grade 10,616 digitized prostate biopsies, "the algorithms achieved agreements of 0.862...[compared with] 0.868 with expert uropathologists."
To read more about the PANDA Challenge, click here.
Source mentioned: Bulten W, Kartasalo K, Chen P-HC, et al. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge. Nature Medicine; Published online 13 January 2022. DOI: https://doi.org/10.1038/s41591-021-01620-2
No comments:
Post a Comment